Following the 2025 Annual ASCO Genitourinary Cancers Symposium, Dr. Chandler Park sat down for an interview with CURE® to debate the important thing takeaways from the assembly. One of many key messages that he highlighted was the significance of genetic testing.
Within the interview he said: “I’d extremely encourage that everytime you see an oncologist… ask for genetic testing — not simply germline testing, however somatic.”
Within the interview, he went on to focus on the significance of precision medication, in addition to talk about key trials in genitourinary cancers to return out of the ASCO GU Symposium. Learn right here for extra of our interview with Park, a medical oncologist of Genitourinary Medical Oncology, on the Norton Healthcare Institute, in Louisville, Kentucky.
Transcript:
One key [takeaway from the ASCO GU Symposium] is for sufferers which have prostate most cancers [or those with] household and family members [with prostate cancer]. You will need to [speak with] your oncologist. I assist out on the medical colleges, and I can sense that sure folks go into oncology as a result of they love folks, and [these people] are open to suggestions. Due to this fact, I’d extremely encourage that everytime you see an oncologist, when you’ve got a historical past of prostate most cancers within the household, ask for genetic testing — not simply germline testing, however somatic.
[Speaking to] bladder most cancers, there was one other research that was up to date, and that is one thing that every one sufferers and their relations ought to find out about, and that is referred to as the part 3 NIAGARA research. That is one thing that is relevant at present. So, what is the NIAGRA research? The NIAGRA research evaluated sufferers through which we wish to get a excessive treatment charge. Beforehand, for sufferers that had cystectomy, the usual of care was chemotherapy, surgical procedure after which afterwards was to observe adopted by consideration of immunotherapy, however there was no general survival.
Nevertheless, based mostly on the ASCO GU replace, if a affected person acquired chemotherapy with an immunotherapy referred to as Imfinzi (durvalumab), that they had a a lot increased probability, that after surgical procedure, they might stay cured. Everyone at present that has stage 2 bladder most cancers and acquired remedy earlier than the surgical procedure ought to ask their medical oncologist for chemotherapy and an immunotherapy. Then, after surgical procedure, possibly even take into account immunotherapy afterwards. That is one thing I’d encourage.
Transcript has been edited for readability and conciseness.
For extra information on most cancers updates, analysis and schooling, don’t neglect to subscribe to CURE®’s newsletters right here.
